Generics Makers Urge 3rd Circ. To Nix Price-Fixing Classes

By Matthew Perlman · October 16, 2025, 7:29 PM EDT

Actavis and Mylan have urged the Third Circuit to reverse the certification of two classes of buyers for a pair of medications in the sprawling multidistrict litigation over alleged price-fixing in...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

2:16-md-02724

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016


Case Title

Wockhardt USA LLC, et al

Case Number

25-2219

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025


Case Title

Wockhardt USA LLC, et al

Case Number

25-2220

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025


Case Title

Mylan Inc, et al

Case Number

25-2221

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025


Case Title

Mylan Inc, et al

Case Number

25-2222

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

July 08, 2025